Radiotherapy Market Size Worth USD 7.65 Billion by 2027, According to Latest Study by Emergen Research

The global Radiotherapy Market is expected to reach USD 7.65 Billion by 2027, according to a new report by Emergen Research. The market is estimated to register a CAGR of 3.4% from 2020 to 2027. Rising prevalence of cancer, technological advancement in radiation therapy, and government initiatives are the major factors driving the market growth. However, high cost associated with radiotherapy treatment is expected to restraint the market growth over the forecast period

Cancer is one of the leading causes of death worldwide. According to the World Health Organization (WHO), cancer was responsible for an estimated 9.6 million deaths in 2018. The number is expected to grow up to 10 million by 2020. As per the Globocan estimates, around 18.1 million new cancer cases and 9.6 million cancer deaths are projected to occur by 2025.

Technological advancement in radiation therapy is another major factor driving the market growth. Various government initiatives are being undertaken to spread awareness about cancer and its treatment options. For instance, in May 2019, the Cancer Control Society (CCS) launched a campaign named ‘Detect cancers early’. The initiative was launched with an aim to spread awareness about the importance of early detection of cancer.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/49

However, high cost associated with radiotherapy treatment is expected to hamper market growth over the forecast period. Various side effects such as skin irritation, fatigue, and hair loss are associated with radiation therapy, which may act as a restraint for the market growth.

Stereotactic body radiation therapy (SBRT) which differentiate it from other radiation therapy techniques is a specialized type of radiotherapy used to target cancerous tumors. The main advantage of SBRT over other radiotherapy techniques is that it allows for higher doses of radiation to be delivered to the tumor site while minimizing the exposure of surrounding healthy tissue. This makes SBRT an ideal treatment option for patients with small, localized tumors who are not candidates for surgery.

Some Key Highlights from the Report

• Radiotherapy can be used to treat cancer by either directly targeting tumor cells with high energy radiation or by damaging the DNA of cancer cells so that they can no longer grow or divide. Various technologies like AI, personalization or miniaturization are being integrated with radiotherapy to target the tumor more precisely. Also, the market is shifting from 2D to 3D and 4D radiotherapy, which has resulted in lesser side effects of this cancer treatment.
• The external beam radiotherapy product segment includes linear accelerators, gamma knife, cyberknife, proton therapy systems, and others. The proton therapy systems product segment is projected to grow at the highest CAGR during the forecast period. Proton therapy is an advanced type of radiation treatment that uses proton beams instead of x-rays to treat cancer. Proton therapy is considered to be more effective and precise than traditional radiation therapy, as it can specifically target the tumor while sparing the surrounding healthy tissues.
• On the basis of services, the global radiotherapy market is classified into brachytherapy, teletherapy, and systemic radiation therapy. The systemic radiation therapy services segment is projected to grow at the highest CAGR during the forecast period. Increasing preference for systemic radiation therapy among healthcare professionals, due to its effectiveness in treating various types of cancer, is expected to drive the growth of this services segment.
• On the basis of indications, the global radiotherapy market is classified into brain & central nervous system tumors, breast cancer, gynecologic cancers, gastrointestinal cancers, head & neck cancer, lung cancer, musculoskeletal tumor, and others. The brain & central nervous system tumors indication segment is expected to grow at the highest CAGR during the forecast period. Increasing prevalence of brain & central nervous system tumors is the major factor driving the growth of this indication segment.
• On the basis of end users, the global radiotherapy market is classified into hospitals, oncology centers, and academic & research institutes. The oncology centers end-user segment is expected to grow at the highest CAGR during the forecast period. Increasing prevalence of cancer and growing government initiatives to spread awareness about early detection and treatment of cancer are the major factors driving the growth of this end-user segment.
• North America is anticipated to witness a significant growth in the demand for radiotherapy services owing to the increasing prevalence of cancer and other chronic diseases. Moreover, the availability of advanced healthcare infrastructure and the rising number of hospitals and cancer treatment centers are some of the key factors that are expected to boost market growth in this region.
• Key participants include Varian Medical Systems, Inc. (U.S.), Elekta (Sweden), Accuray Incorporated (U.S.), Ion Beam Applications S.A. (Belgium), Panacea Medical Technologies Pvt. Ltd. (India), ViewRay, Inc. (U.S.), IsoRay Medical, Inc. (U.S.), Provision Healthcare (U.S.), Hitachi Ltd. (Japan), Mevion Medical Systems, Inc. (U.S.) and Reflexion Medical (U.S.) among others.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/radiotherapy-market

Emergen Research have segmented the global Radiotherapy Market on the basis of products, types, applications, end-users, and region:

Products Outlook (Revenue in Million USD; 2017–2027)

• External Beam Radiotherapy Product
  • Linear Accelerators (LINAC)
    1. Conventional LINAC
    2. Stereotactic Advanced Electron/Cobalt-60 LINAC
       1. CyberKnife
       2. Gamma Knife
       3. TomoTherapy
    3. Particle Therapy Systems
       1. Cyclotrons
       2. Synchrotrons
       3. Synchrocyclotrons
    4. Conventional Cobalt-60 Teletherapy Units
  • Internal Beam Radiotherapy/Brachytherapy Products
    1. Seeds
    2. Applicators
    3. Afterloaders
    4. Electronic Brachytherapy Products
  • Systemic Radiotherapy
    1. Iobenguane-131
    2. Samarium-153
    3. Rhenium-186
    4. Yttrium-90
    5. Radium-223
    6. Phosphorous-32
    7. Radio-Labelled Antibodies

Types Outlook (Revenue in Million USD; 2017–2027)

• External Beam Radiotherapy
  1. Image-guided Radiotherapy (IGRT)
  2. Intensity-modulated Radiotherapy (IMRT)
     1. TomoTherapy
     2. Volumetric Modulated Arc Therapy (VMAT)
  3. Stereotactic Therapy
  4. 3D Conformal Radiotherapy (3D-CRT)
  5. Particle Beam Therapy (Heavy-ion and Proton Therapy)
• Internal Beam Radiotherapy/Brachytherapy
  1. Low-dose-rate (LDR) Brachytherapy
  2. High-dose-rate (HDR) Brachytherapy
  3. Pulsed-dose-rate (PDR) Brachytherapy
• Systemic Radiotherapy
  1. Intravenous Radiotherapy
  2. Oral Radiotherapy
  3. Instillation Radiotherapy

Applications Outlook (Revenue in Million USD; 2017–2027)

• Prostate Cancer
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Spine Cancer
• Brain Cancer
• Pediatric Cancer
• Gynecological Cancer
• Cervical Cancer
• Penile Cancer
• Head and Neck Cancer

End Use Outlook (Revenue in Million USD; 2017–2027)

• Hospitals
• Independent Radiotherapy Centers

Regional Outlook (Revenue in Million USD; 2017–2027)

• North America
  1. U.S
  2. Canada
• Europe
  1. Germany
  2. France
  3. UK
  4. Spain
  5. Italy
  6. Rest of the Europe
• Asia Pacific
  1. China
  2. India
  3. Japan
  4. Rest of Asia-Pacific
• Middle East & Africa
• Latin America
  1. Brazil

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/49

Explore More Reports Emergen Research:

Nucleic Acid Isolation and Purification Market

Telepresence Robot Market

3D Holographic Display and Services Market

Bioanalytical Testing Services Market

Cellulose-Based Plastics Market

Electric Vehicle ECU Market

Alternative Proteins Market

Industrial Sensors Market

Organic Electronics Market

Minimally Invasive Surgical Systems Market

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Emergen Research Media Citations: https://www.emergenresearch.com/media-citations

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Press Release Available @ https://www.emergenresearch.com/press-release/global-radiotherapy-market

Read Our Blog@ https://www.emergenresearch.com/blog/advancements-in-delivery-of-radiotherapy-to-fuel-growth-of-radiotherapy-market